• Je něco špatně v tomto záznamu ?

The PCNA-associated protein PARI negatively regulates homologous recombination via the inhibition of DNA repair synthesis

P. Burkovics, L. Dome, S. Juhasz, V. Altmannova, M. Sebesta, M. Pacesa, K. Fugger, CS. Sorensen, MY. Lee, L. Haracska, L. Krejci,

. 2016 ; 44 (7) : 3176-89. [pub] 20160120

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc16027731

Successful and accurate completion of the replication of damage-containing DNA requires mainly recombination and RAD18-dependent DNA damage tolerance pathways. RAD18 governs at least two distinct mechanisms: translesion synthesis (TLS) and template switching (TS)-dependent pathways. Whereas TS is mainly error-free, TLS can work in an error-prone manner and, as such, the regulation of these pathways requires tight control to prevent DNA errors and potentially oncogenic transformation and tumorigenesis. In humans, the PCNA-associated recombination inhibitor (PARI) protein has recently been shown to inhibit homologous recombination (HR) events. Here, we describe a biochemical mechanism in which PARI functions as an HR regulator after replication fork stalling and during double-strand break repair. In our reconstituted biochemical system, we show that PARI inhibits DNA repair synthesis during recombination events in a PCNA interaction-dependent way but independently of its UvrD-like helicase domain. In accordance, we demonstrate that PARI inhibits HR in vivo, and its knockdown suppresses the UV sensitivity of RAD18-depleted cells. Our data reveal a novel human regulatory mechanism that limits the extent of HR and represents a new potential target for anticancer therapy.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16027731
003      
CZ-PrNML
005      
20161027120013.0
007      
ta
008      
161005s2016 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/nar/gkw024 $2 doi
024    7_
$a 10.1093/nar/gkw024 $2 doi
035    __
$a (PubMed)26792895
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Burkovics, Peter $u Institute of Genetics, Biological Research Center, Hungarian Academy of Sciences, 6726 Szeged, Hungary Department of Biology, Masaryk University, 625 00 Brno, Czech Republic burkovics.peter@brc.mta.hu.
245    14
$a The PCNA-associated protein PARI negatively regulates homologous recombination via the inhibition of DNA repair synthesis / $c P. Burkovics, L. Dome, S. Juhasz, V. Altmannova, M. Sebesta, M. Pacesa, K. Fugger, CS. Sorensen, MY. Lee, L. Haracska, L. Krejci,
520    9_
$a Successful and accurate completion of the replication of damage-containing DNA requires mainly recombination and RAD18-dependent DNA damage tolerance pathways. RAD18 governs at least two distinct mechanisms: translesion synthesis (TLS) and template switching (TS)-dependent pathways. Whereas TS is mainly error-free, TLS can work in an error-prone manner and, as such, the regulation of these pathways requires tight control to prevent DNA errors and potentially oncogenic transformation and tumorigenesis. In humans, the PCNA-associated recombination inhibitor (PARI) protein has recently been shown to inhibit homologous recombination (HR) events. Here, we describe a biochemical mechanism in which PARI functions as an HR regulator after replication fork stalling and during double-strand break repair. In our reconstituted biochemical system, we show that PARI inhibits DNA repair synthesis during recombination events in a PCNA interaction-dependent way but independently of its UvrD-like helicase domain. In accordance, we demonstrate that PARI inhibits HR in vivo, and its knockdown suppresses the UV sensitivity of RAD18-depleted cells. Our data reveal a novel human regulatory mechanism that limits the extent of HR and represents a new potential target for anticancer therapy.
650    _2
$a aminokyselinové motivy $7 D020816
650    _2
$a DNA $x biosyntéza $7 D004247
650    _2
$a DNA-polymerasa III $x antagonisté a inhibitory $7 D004258
650    _2
$a DNA vazebné proteiny $x chemie $x metabolismus $x fyziologie $7 D004268
650    _2
$a HEK293 buňky $7 D057809
650    _2
$a lidé $7 D006801
650    12
$a rekombinační oprava DNA $7 D059767
650    _2
$a ubikvitinligasy $x fyziologie $7 D044767
650    _2
$a ultrafialové záření $7 D014466
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Dome, Lili $u Institute of Genetics, Biological Research Center, Hungarian Academy of Sciences, 6726 Szeged, Hungary.
700    1_
$a Juhasz, Szilvia $u Institute of Genetics, Biological Research Center, Hungarian Academy of Sciences, 6726 Szeged, Hungary.
700    1_
$a Altmannová, Veronika $u Department of Biology, Masaryk University, 625 00 Brno, Czech Republic. $7 mub2011626283
700    1_
$a Sebesta, Marek $u Department of Biology, Masaryk University, 625 00 Brno, Czech Republic National Centre for Biomolecular Research, Masaryk University, 625 00 Brno, Czech Republic International Clinical Research Center, Center for Biomolecular and Cellular Engineering, St Anne's University Hospital Brno, 656 91 Brno, Czech Republic.
700    1_
$a Pacesa, Martin $u Department of Biology, Masaryk University, 625 00 Brno, Czech Republic.
700    1_
$a Fugger, Kasper $u Biotech Research and Innovation Centre, University of Copenhagen, 2200 Copenhagen, Denmark.
700    1_
$a Sorensen, Claus Storgaard $u Biotech Research and Innovation Centre, University of Copenhagen, 2200 Copenhagen, Denmark.
700    1_
$a Lee, Marietta Y W T $u Department of Biochemistry and Molecular Biology, New York Medical College, Valhalla, 10595 NY, USA.
700    1_
$a Haracska, Lajos $u Institute of Genetics, Biological Research Center, Hungarian Academy of Sciences, 6726 Szeged, Hungary.
700    1_
$a Krejci, Lumir $u Department of Biology, Masaryk University, 625 00 Brno, Czech Republic National Centre for Biomolecular Research, Masaryk University, 625 00 Brno, Czech Republic International Clinical Research Center, Center for Biomolecular and Cellular Engineering, St Anne's University Hospital Brno, 656 91 Brno, Czech Republic lkrejci@chemi.muni.cz.
773    0_
$w MED00003554 $t Nucleic acids research $x 1362-4962 $g Roč. 44, č. 7 (2016), s. 3176-89
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26792895 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20161005 $b ABA008
991    __
$a 20161027120430 $b ABA008
999    __
$a ok $b bmc $g 1166045 $s 952361
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 44 $c 7 $d 3176-89 $e 20160120 $i 1362-4962 $m Nucleic acids research $n Nucleic Acids Res $x MED00003554
LZP    __
$a Pubmed-20161005

Najít záznam

Citační ukazatele

Možnosti archivace